Found 5 results
Name | Type of Offering | Accepted Date |
---|---|---|
CuraSen Therapeutics, Inc.
See All Filings
|
D | 2022-11-10 13:14:24 |
Amount To Be Raised
$14,999,997
Associated Brokers / Dealers
N/A
CIK Number
0001765883
Filed Document
0001567619-22-019469
Exclusions or Exemptions
506b
Accepted Date
2022-11-10 13:14:24
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
CuraSen Therapeutics, Inc.
See All Filings
|
D/A | 2023-10-12 15:49:48 |
Amount To Be Raised
$20,814,709
Associated Brokers / Dealers
N/A
CIK Number
0001765883
Filed Document
0001567619-23-007439
Exclusions or Exemptions
506b
Accepted Date
2023-10-12 15:49:48
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
CuraSen Therapeutics, Inc.
See All Filings
|
D | 2019-01-24 20:04:16 |
Amount To Be Raised
$54,499,989
Associated Brokers / Dealers
N/A
CIK Number
0001765883
Filed Document
0001765883-19-000001
Exclusions or Exemptions
506c
Accepted Date
2019-01-24 20:04:16
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
CuraSen Therapeutics, Inc.
See All Filings
|
D | 2021-11-05 17:02:42 |
Amount To Be Raised
$18,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001765883
Filed Document
0001567619-21-019414
Exclusions or Exemptions
506b
Accepted Date
2021-11-05 17:02:42
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
CuraSen Therapeutics, Inc.
See All Filings
|
D | 2024-09-18 16:56:47 |
Amount To Be Raised
$45,690,305
Associated Brokers / Dealers
N/A
CIK Number
0001765883
Filed Document
0001765883-24-000002
Exclusions or Exemptions
506b
Accepted Date
2024-09-18 16:56:47
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|